mHealth Intelligence January 4, 2024
Anuja Vaidya

MIT engineers developed an ingestible device that activates receptors in the stomach indicating satiety, making it a new minimally invasive obesity treatment.

Engineers at the Massachusetts Institute of Technology (MIT) have developed an ingestible capsule that vibrates within the stomach to create a sense of fullness, potentially helping treat obesity.

Obesity is a common and severe disease in the United States. According to the Centers for Disease Control and Prevention, obesity prevalence was 41.9 percent between 2017 and March 2020. Obesity can result in various chronic conditions, including heart disease, type 2 diabetes, and certain types of cancer.

In a study published in Science Advances, the MIT engineers noted that obesity therapies are typically invasive, involving surgery or endoscopic interventions,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Patient / Consumer, Provider, Survey / Study, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article